These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 28415395)

  • 1. Drug kinetics release from Eudragit - Tenofovir@SiOC tablets.
    Tamayo A; Mazo MA; Veiga MD; Ruiz-Caro R; Notario-Pérez F; Rubio J
    Mater Sci Eng C Mater Biol Appl; 2017 Jun; 75():1097-1105. PubMed ID: 28415395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanostructure-loaded mesoporous silica for controlled release of coumarin derivatives: a novel testing of the hyperthermia effect.
    Al-Kady AS; Gaber M; Hussein MM; Ebeid el-ZM
    Eur J Pharm Biopharm; 2011 Jan; 77(1):66-74. PubMed ID: 20974253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silicon Oxycarbide Porous Particles and Film Coating as Strategies for Tenofovir Controlled Release in Vaginal Tablets for HIV Prevention.
    Martín-Illana A; Cazorla-Luna R; Notario-Pérez F; Ruiz-Caro R; Rubio J; Tamayo A; Veiga MD
    Pharmaceutics; 2022 Jul; 14(8):. PubMed ID: 36015193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of Chitosan Swelling Behaviour on Controlled Release of Tenofovir from Mucoadhesive Vaginal Systems for Prevention of Sexual Transmission of HIV.
    Notario-Pérez F; Martín-Illana A; Cazorla-Luna R; Ruiz-Caro R; Bedoya LM; Tamayo A; Rubio J; Veiga MD
    Mar Drugs; 2017 Feb; 15(2):. PubMed ID: 28230790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of tenofovir release from mucoadhesive vaginal tablets by polymer combination to prevent sexual transmission of HIV.
    Notario-Pérez F; Cazorla-Luna R; Martín-Illana A; Ruiz-Caro R; Tamayo A; Rubio J; Veiga MD
    Carbohydr Polym; 2018 Jan; 179():305-316. PubMed ID: 29111056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel strategy to design sustained-release poorly water-soluble drug mesoporous silica microparticles based on supercritical fluid technique.
    Li-Hong W; Xin C; Hui X; Li-Li Z; Jing H; Mei-Juan Z; Jie L; Yi L; Jin-Wen L; Wei Z; Gang C
    Int J Pharm; 2013 Sep; 454(1):135-42. PubMed ID: 23871738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eudragit NE30D based metformin/gliclazide extended release tablets: formulation, characterisation and in vitro release studies.
    Arno EA; Anand P; Bhaskar K; Ramachandran S; Saravanan M; Vinod R
    Chem Pharm Bull (Tokyo); 2002 Nov; 50(11):1495-8. PubMed ID: 12419917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aminosilane-grafted polymer/silica hollow fiber adsorbents for CO₂ capture from flue gas.
    Rezaei F; Lively RP; Labreche Y; Chen G; Fan Y; Koros WJ; Jones CW
    ACS Appl Mater Interfaces; 2013 May; 5(9):3921-31. PubMed ID: 23540568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of thermal treatment and type of insoluble poly(meth)acrylates on dissolution behavior of very soluble drug from hypromellose matrix tablets evaluated by multivariate data analysis.
    Kubova K; Peček D; Hasserová K; Doležel P; Pavelková M; Vyslouzil J; Muselík J; Vetchy D
    Pharm Dev Technol; 2017 Mar; 22(2):206-217. PubMed ID: 28058866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel double-coating approach for improved pH-triggered delivery to the ileo-colonic region of the gastrointestinal tract.
    Liu F; Moreno P; Basit AW
    Eur J Pharm Biopharm; 2010 Feb; 74(2):311-5. PubMed ID: 19932177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled drug delivery system based on ordered mesoporous silica matrices of captopril as angiotensin-converting enzyme inhibitor drug.
    Popovici RF; Seftel EM; Mihai GD; Popovici E; Voicu VA
    J Pharm Sci; 2011 Feb; 100(2):704-14. PubMed ID: 20740675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risedronate-loaded Eudragit S100 microparticles formulated into tablets.
    Velasquez AA; Mattiazzi J; Ferreira LM; Pohlmann L; Silva CB; Rolim CM; Cruz L
    Pharm Dev Technol; 2014 May; 19(3):263-8. PubMed ID: 23506303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pH dependent delivery of mesalazine from polymer coated and drug-loaded SBA-16 systems.
    Trendafilova I; Szegedi Á; Yoncheva K; Shestakova P; Mihály J; Ristić A; Konstantinov S; Popova M
    Eur J Pharm Sci; 2016 Jan; 81():75-81. PubMed ID: 26453768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monte-Carlo multiscale simulation study of argon adsorption/desorption hysteresis in mesoporous heterogeneous tubular pores like MCM-41 or oxidized porous silicon.
    Puibasset J
    Langmuir; 2009 Jan; 25(2):903-11. PubMed ID: 19063620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled release of vitamin B2 using mesoporous materials functionalized with amine-bearing gate-like scaffoldings.
    Bernardos A; Aznar E; Coll C; Martínez-Mañez R; Barat JM; Marcos MD; Sancenón F; Benito A; Soto J
    J Control Release; 2008 Nov; 131(3):181-9. PubMed ID: 18727946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained release of heparin on enlarged-pore and functionalized MCM-41.
    Wan MM; Yang JY; Qiu Y; Zhou Y; Guan CX; Hou Q; Lin WG; Zhu JH
    ACS Appl Mater Interfaces; 2012 Aug; 4(8):4113-22. PubMed ID: 22850329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation of thin polymer films with drug release and protein adsorption resistance.
    Tsukagoshi T; Kondo Y; Yoshino N
    Colloids Surf B Biointerfaces; 2007 Mar; 55(1):19-25. PubMed ID: 17161591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and fabrication of branched polyamine functionalized mesoporous silica: an efficient absorbent for water remediation.
    Nayab S; Farrukh A; Oluz Z; Tuncel E; Tariq SR; ur Rahman H; Kirchhoff K; Duran H; Yameen B
    ACS Appl Mater Interfaces; 2014 Mar; 6(6):4408-17. PubMed ID: 24564236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seventy-two-hour release formulation of the poorly soluble drug silybin based on porous silica nanoparticles: in vitro release kinetics and in vitro/in vivo correlations in beagle dogs.
    Cao X; Deng W; Fu M; Zhu Y; Liu H; Wang L; Zeng J; Wei Y; Xu X; Yu J
    Eur J Pharm Sci; 2013 Jan; 48(1-2):64-71. PubMed ID: 23123331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eudragit(®) RS PO/RL PO as rate-controlling matrix-formers via roller compaction: Influence of formulation and process variables on functional attributes of granules and tablets.
    Dave VS; Fahmy RM; Bensley D; Hoag SW
    Drug Dev Ind Pharm; 2012 Oct; 38(10):1240-53. PubMed ID: 22257339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.